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Abstract
The spalt proteins are encoded by a family of evolutionarily conserved genes found in species as diverse as Drosophila, C. elegans and
vertebrates. In humans, mutations in some of these genes are associated with several congenital disorders which underscores the importance of
spalt gene function in embryonic development. Recent studies have begun to cast light on the functions of this family of proteins with increasing
understanding of the developmental processes regulated and the molecular mechanisms used. Here we review what is currently known about the
role of spalt genes in vertebrate development and human disease.
© 2006 Elsevier Inc. All rights reserved.
Keywords: Spalt; SALL; Sall; Townes–Brocks; Holt–Oram; Okihiro
Introduction
The spalt genes were originally identified in Drosophila,
which has two members of the family, spalt major (salm) and
spalt related (salr). These have important roles in processes as
diverse as homeotic specification of the embryonic termini
(Jürgens, 1988; Kuhnlein et al., 1994), wing patterning (de Celis
and Barrio, 2000), sensory organ development (de Celis et al.,
1999), tracheal system development (Kuhnlein and Schuh,
1996) and specification of photoreceptors (Domingos et al.,
2004a,b). Vertebrate homologues of spalt have been shown to be
involved in normal development and are implicated in several
human genetic disorders. Here wewill review the developmental
roles of this gene family with reference to both animal model
organisms and human disease. The spalt genes are known to be
mutated in several human congenital syndromes and studies of
the mutations associated with these syndromes have been critical
in our current understanding of spalt gene function. Finally, we
will discuss how the developmental and disease studies relate to
what is currently known about the structure/function of these
proteins. We will also discuss the relationships between these
genes and propose a unified nomenclature system for future use
(see box, Fig. 1 and Table 1).
Spalt proteins in development
Recent work has demonstrated that spalt genes are required
for the normal development of the limbs and nervous system
and several organs including the kidney and heart. In this
section, we discuss which members of this gene family are
necessary in these systems, the mechanisms by which they are
thought to act and highlight some of the as yet unanswered
questions about these genes in development.
Limb development
The association of several syndromes affecting normal limb
development with mutations in the SALL genes suggests a
critical role of these proteins in the limb. Several members of the
spalt family are known to be expressed during limb develop-
ment including Sall1, Sall3 and Sall4 in mouse (Buck et al.,
2001; Kohlhase et al., 2002a; Ott et al., 1996, 2001), csall1,
csall3 and csall4 in chick (Barembaum and Bronner-Fraser,
2004; Farrell and Münsterberg, 2000; Farrell et al., 2001) and
Xsall3 and Xsall4a in Xenopus (Hollemann et al., 1996; Neff
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et al., 2005). These genes are expressed in overlapping patterns
and may well affect limb patterning and development in a co-
coordinated way. Very little is known about the regulation of
spalt genes in the developing limb; however, it has been shown
that endogenous csall1 expression in the distal part of the limb
bud requires FGF and Wnt signaling (Farrell and Münsterberg,
2000). In the proximal limb, csall1 expression can be induced
ectopically by BMP-2 although this may reflect an induction of
distal limb fate in this case rather than endogenous regulation
(Capdevila et al., 1999). The range of possible interactions
between different spalt proteins will vary across the limb bud
depending on the precise combination of spalt proteins present
and it is tempting to speculate that this could modulate function
and produce different activities in different areas. For example
in part of the chick limb bud, csall1 is coexpressed with csall3.
It is known that the chick protein csall3 is cytoplasmic and can
remove full-length spalt protein from the nucleus, providing
another possible level of regulation of protein activity (Sweet-
man et al., 2003). In the mouse limb, no defects are observed in
loss of function Sall1 mutations but patterning is disrupted in
the presence of truncated Sall1 protein (McLeskey Kiefer et al.,
2003; Nishinakamura et al., 2001). These findings are discussed
further in the section on SALL1 in Townes–Brocks syndrome
(TBS) below. In Xenopus, Xsall4a is expressed both during
normal limb development and regeneration (Neff et al., 2005).
Recent evidence has also shown that in zebrafish sall1 and sall4
are regulated by tbx5 in pectoral fin development and are
required for regulation of FGF signaling (Harvey and Logan,
2006). The control of these genes by tbx5 may explain the
clinical overlap between Holt–Oram syndrome and Okihiro
syndrome with mutations in TBX5 and SALL4 giving
remarkably similar phenotypes (see SALL4 in developmental
disorders).
The details of how spalt proteins affect limb patterning are
unclear but one possibility is that they interact genetically with
members of the Iroquois gene family. These genes are expressed
during vertebrate limb development (Houweling et al., 2001;
Zulch et al., 2001) and in Drosophila it is known that
interactions between the spalt and iroquois gene families are
required in wing patterning (de Celis and Barrio, 2000).
Nomenclature
Vertebrate spalt proteins fall into four groups, with four genes in human called SALL1-4 (Kohlhase et al., 1996, 1999,
2002b). Four genes have been identified in mouse, Sall1-4 (Buck et al., 2001; Kohlhase et al., 2000, 2002a; Ott et al., 1996,
2001), three in chick (Barembaum and Bronner-Fraser, 2004; Farrell and Münsterberg, 2000; Farrell et al., 2001), five in
Xenopus (Hollemann et al., 1996; Neff et al., 2005; Onai et al., 2004; Onuma et al., 1999), three in zebrafish (Camp et al., 2003)
and one in Medaka (Koster et al., 1997). A phylogenetic tree indicating the relationship of these homologues is shown in Fig. 1.
The nomenclature for these genes is not entirely consistent and for the purposes of clarity in this review we will refer to all
vertebrate spalt genes as spalt like (abbreviated sall). Table 1 shows our proposed nomenclature based on this phylogeny.
Human and mouse genes retain their current names while those of other species have been changed to correspond to these
genes. As Fig. 1 shows, the spalt genes fall into four distinct groups with the SALL1 and SALL3 groups being most closely
related. This phylogeny suggests that an ancestral spalt diverged to produce the SALL2 group with further duplications
producing the SALL4 group and then the SALL1 and SALL3 groups. The status of the zebrafish sall1b is least clear. Comparison
of protein sequences shows that it has 55.2% identity with zebrafish sall1 and 52.4% identity with zebrafish sall3 and it is
possible that this gene is of a subfamily unique to zebrafish.
Fig. 1. Clustal alignment of vertebrate spalt protein sequences. Four orthologous groups can be identified based on sequence similarity, which are termed SALL1,
SALL2, SALL3 and SALL4 groups based on the human gene.
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Heart development
In the developing heart, expression has been reported of Sall1
in mouse (Buck et al., 2001; Ott et al., 2001), sall1 in zebrafish
(Camp et al., 2003) and csall1 in chick (Sweetman et al., 2005).
Together with the presence of heart defects in TBS (Kohlhase et
al., 2003a) (see SALL1 in Townes–Brocks syndrome), this is
strongly suggestive of a role in heart development. Interestingly
in the developing chick embryo, csall1 expression is observed
not only in the sinus venosus of the heart itself but also in the
pharynx at the same axial level (Sweetman et al., 2005). The
pharynx is known to be involved in the inductive events required
for cardiac neural crest specification and disruptions to this
population of cells can result in ventral septal defect and
Tetralogy of Fallot (Creazzo et al., 1998; Farrell et al., 1999).
These defects are also occasionally seen in TBS. This would be
consistent with an additional indirect role of csall1 in heart
development via the regulation of inductive events mediated by
the pharynx.
Neural development
Many spalt genes are expressed in the developing nervous
system; however, only recently have studies begun to cast light
on the function of these genes in neural development. In
Xenopus, Xsall2 has been shown to be required for the
determination of the forebrain/midbrain and for repressing the
acquisition of a more caudal midbrain/hindbrain fate. It is
interesting to note that in this context Xsall2 acts by repressing
canonical Wnt signaling which acts to posteriorize the neural
tissue in the absence of Xsall2 (Onai et al., 2004). This is in
contrast to the reported ability of Sall1 to enhance canonical
Wnt signaling (Sato et al., 2004) and it remains to be determined
whether this difference is due to cellular context or to different
properties of these spalt proteins. Another report shows that in
the chick embryo csall4 expression is required for the correct
migration of neural crest cells into the sensory ganglia. Neural
crest cells overexpressing csall4 do not migrate normally into
the ganglia and do not express differentiation markers. The
authors suggest that csall4 is required for these cells to remain
undifferentiated and that this could affect the ability of these
cells to form neurons (Barembaum and Bronner-Fraser, 2004).
Cranial nerve development is also disrupted in a Sall3 null
mouse model. In these mice, the nerves that innervate the oral
cavity do not form normally, particularly the glossopharyngeal
nerve (Parrish et al., 2004). Together, these studies demonstrate
important and varied roles for the spalt genes in the normal
development of the nervous system.
Kidney development
Mice homozygous for a null mutation in Sall1 die perinatally
due to renal agenesis. In these animals, the uteric bud does not
grow out, tubules do not form and the metanephric mesenchyme
undergoes apoptosis. Although these defects occur in the
nephrogenic mesenchyme, the mesenchyme itself can be
rescued by wild type tissue. Therefore, it is the inductive
signals leading to uteric bud invasion that fail under these
conditions (Nishinakamura et al., 2001). In another mouse
model where a truncated Sall1 protein is expressed, homozy-
gous mice have renal agenesis, while in heterozygous mice with
one wild type Sall1 allele renal cystic hypoplasia results
(McLeskey Kiefer et al., 2003). Another link between SALL1
and kidney development comes from studies of patients with
Townes–Brocks syndrome which is associated with kidney
defects (Powell and Michaelis, 1999). In other species, spalt
genes are also expressed in the developing kidney with sall1a in
zebrafish and Xsall4b in Xenopus expressed in the pronephric
ducts (Camp et al., 2003; Onuma et al., 1999) while in the chick
embryo csall3 is expressed in the mesonephros (Farrell et al.,
2001). The range of different spalt genes expressed in kidney
development in different species suggests some divergence in
function with other spalt genes substituting for SALL1 in both
Xenopus and chick embryos.
Future directions
The regulation of spalt gene expression has not yet been
examined in detail in most of the organ systems known to
require these genes. The regulation ofDrosophila spalt has been
studied and shown to respond to a gradient of the TGFβ
homologue dpp (Barrio et al., 1999; Smith, 1996) and the T box
gene omb (del Alamo Rodriguez et al., 2004); in vertebrates the
only known regulators are Shh in the Medaka midbrain/
hindbrain boundary (Koster et al., 1997) and FGF and Wnt
signaling in the distal limb bud (Farrell and Münsterberg, 2000)
although BMP signaling can induce ectopic csall1 expression in
the proximal limb (Capdevila et al., 1999). Further elucidation
of the spatio-temporal regulation will be critical in the
understanding of how these proteins are able to affect the
Table 1
Proposed new nomenclature of the vertebrate spalt like genes
Current
name
Species Genbank
accession no.
Reference Proposed
name
csal1 Chick NM_204707 (Capdevila et al.,
1999; Farrell and
Münsterberg, 2000)
csall1
csal3 Chick NM_204647 (Farrell et al., 2001;
Sweetman et al.,
2003)
csall3
csal4 Chick AAR01968 (Barembaum and
Bronner-Fraser, 2004)
csall4
Xsal1 Xenopus
leavis
L46583 (Hollemann et al.,
1996)
Xsall3
Xsal1 Xenopus
leavis
AF310007 Unpublished Xsall1
Xsal3 Xenopus
leavis
AB030827 (Onuma et al., 1999) Xsall4b
Xlsall4 Xenopus
leavis
AAH82637 (Neff et al., 2005) Xsall4a
XsalF Xenopus
leavis
AY508953 (Onai et al., 2004) Xsall2
sall1a Zebrafish AJ293862 (Camp et al., 2003) sall1
sall1b Zebrafish AJ293863 (Camp et al., 2003) sall1b
sall3 Zebrafish AJ293864 (Camp et al., 2003) sall3
sal Medaka AAB51127 (Koster et al., 1997) Msall3
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patterning of different tissues as downstream effectors of
developmental signaling cascades.
InDrosophilawing development, sal regulates expression of
the Iroquois complex and knirps (de Celis and Barrio, 2000) and
is itself controlled by the T box gene optomotor blind (del
Alamo Rodriguez et al., 2004). In vertebrate limb development,
homologues of these genes are known to be required for normal
patterning and mutations in one vertebrate T box gene, TBX5,
also lead to Holt–Oram syndrome, as can mutations in SALL4.
The discovery that tbx5 regulates sall1 and sall4 in zebrafish
pectoral fin development (Harvey and Logan, 2006) and that
Tbx5 and Sall4 interact in mouse heart and limb development
(Koshiba-Takeuchi et al., 2006) underscores the conservation of
spalt gene function across species. In the future, it will be
fascinating to determine if other functional relationships known
from Drosophila are also conserved in vertebrates, such as the
interaction between spalt and Iroquis gene families, and what
implications this has for normal limb development.
Another area that is currently not well understood is the role
of spalt genes in ear development. This is of particular interest
as mutations in some human spalt genes lead to outer ear and
auditory defects. Unpublished data from chick embryos indicate
that csall4 is required for the invagination of sensory placodes
(M. Bronner Fraser, personal communication) and this will be
an exciting area for further investigation.
Spalt genes in human disease
One of the striking aspects of spalt biology is the clear
association of mutations within this gene family with congenital
syndromes affecting limb, ear, kidney and heart development.
Much of the work on developmental aspects of spalt gene
function has been based on information from studies of these
patients. In this section, we describe the relationships between
these syndromes and mutations in the human spalt genes and
how these have provided valuable insights into the function of
these proteins in normal development.
SALL1 in Townes–Brocks syndrome
Townes–Brocks syndrome (TBS) is an autosomal dominant
disorder characterized by preaxial polydactyly and triphalangeal
thumbs, external ear defects and sensorineural hearing loss,
imperforate anus, kidney defects and heart defects including
Tetralogy of Fallot and ventricular septal defects (Powell and
Michaelis, 1999) with some rare cases of patients also showing
a variety of other phenotypic anomalies (Botzenhart et al.,
2005). Mutations in SALL1 have been shown to result in TBS
(Kohlhase et al., 1998). Most of these mutations cause
premature stop codons in the 5′ region of the gene which, if
transcribed, would lead to the production of truncated forms of
the SALL1 protein that terminate after the glutamine rich region
and around the region of the first set of C2H2 zinc fingers
leading to a predicted protein containing either none or only one
of the C2H2 domains (Botzenhart et al., 2005; Kohlhase, 2000)
(see Fig. 2). The question of whether or not these mutations
actually lead to the expression of truncated SALL1 proteins has
not been resolved and initial reports suggested that TBS is
caused by haploinsuffiency at the SALL1 locus caused by
nonsense-mediated decay of the mutant transcript (Kohlhase et
al., 1998). This hypothesis did not explain the clustering of
mutations and several studies have suggested an alternative
possibility, namely that truncated proteins produced from the
SALL1 locus can act in a dominant negative manner, interfering
with the function of full-length SALL1 protein. Intriguingly
transfection experiments have shown that truncated proteins
similar to those potentially present in TBS patients are
expressed throughout the cell. They can interact with full-
length spalt proteins and can cause full-length protein to be
relocalized from the nucleus to the cytoplasm providing a
potential mechanism of dominant negative interference
(McLeskey Kiefer et al., 2003; Sweetman et al., 2003). Studies
in transgenic mice also support the idea of dominant negative
activity by truncated spalt protein. Mice completely lacking
Sall1 show renal agenesis but lack the features associated with
TBS (Nishinakamura et al., 2001). If haploinsufficiency is
indeed the underlying cause of TBS in human, then mice
carrying null alleles of Sall1 might be expected to show a
phenotype similar to that seen in TBS even though transgenic
and knock out mice do not always completely recapitulate
human disease phenotypes; however, heterozygous Sall1 null
mice have no apparent defects. In contrast, mice carrying a
knock-in into the Sall1 locus of a cDNA encoding a protein with
a truncation similar to that predicted to be present in TBS have a
range of defects much more reminiscent of TBS including
sensorineural hearing loss, renal cystic hypoplasia and limb
abnormalities (McLeskey Kiefer et al., 2003). That truncating
mutations of SALL1 orthologues can affect the function of full-
length protein has been well established in vitro; however, so far
truncated proteins have not been detected in TBS patients.
Recently, further evidence has shown that some TBS patients
carry deletions which entirely remove one SALL1 allele and in
Fig. 2. Schematic representation of the predicted structure of human spalt
proteins. The N terminal zinc finger (NT ZF) is of the C2HC type while the other
zinc fingers (ZF 1–9) are of the C2H2 type. The Q rich region mediates
interactions betweenmembers of this protein family. Themutations found in TBS
are clustered between the Q rich region and the first set of C2H2 zinc fingers (ZF
1–2). The double asterisks (**) indicate the position of the zinc fingers present in
Xsall2 but not in SALL2. The double sign (§§) indicates the zinc fingers missing
in the orthologous gene csall3. The black circles indicate the C terminal zinc
fingers in SALL2 which are not homologous to those in other spalt proteins.
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these cases haploinsufficiency can safely be assumed to lead to
TBS; however, it is interesting to note that these cases show a
milder phenotype than those associated with truncating
mutations in SALL1 (Borozdin et al., 2006). One plausible
interpretation of these data is that while loss of one SALL1 allele
can cause TBS, a truncated protein has a stronger effect and
produces a more severe phenotype. The potential dominant
negative activity of truncated spalt proteins also raises the
possibility that truncated SALL1 protein could interact with and
affect the function of other spalt proteins as these truncations are
able to interact with all full-length spalt genes so far tested
(McLeskey Kiefer et al., 2003; Sweetman et al., 2003). For
example in limb development at least three spalt proteins (1, 3
and 4) are known to be expressed in partially overlapping
domains and the presence of a truncated SALL1 protein could
therefore potentially affect the functioning of all of them. Thus,
it may be the case that TBS is caused by interfering with the
function of multiple SALL proteins during embryonic devel-
opment. Interestingly, in Drosophila, flies carrying mutations in
both spalt and spalt related show defects in antennal, genital
and auditory defects, remarkable evidence of functional
conservation of spalt gene function across vertebrate and
invertebrate development (Dong et al., 2003).
While TBS is the best understood of the diseases caused by
spalt gene defects, there remain some unanswered questions. In
Townes–Brocks syndrome, the truncating mutations in SALL1
are potentially able to interfere with the activity of any other
spalt gene coexpressed in the same cell. Based on mouse
models, it appears that the kidney defects observed may well be
due to reduced function of SALL1 protein while the patterning
defects in the ear and limb are likely to be caused by dominant
negative effects on other members of the family expressed in
these tissues as well as SALL1 (McLeskey Kiefer et al., 2003;
Nishinakamura et al., 2001). The requirement for csall4 in the
invagination of sensory placodes (M. Bronner Fraser, personal
communication) is consistent with the idea that the ear defects
seen in TBS may result from interference with SALL4 as well as
SALL1.
SALL4 in developmental disorders
Mutations in SALL4 have been found in a range of clinically
overlapping syndromes including Okihiro syndrome (also
known as acro-renal-ocular syndrome or Duane radial ray syn-
drome), Holt–Oram syndrome and some cases previously
thought to be thalidomide embryopathy (Borozdin et al.,
2004a,b; Kohlhase et al., 2002b, 2003b). These syndromes
present with defects in limb and heart development with Okihiro
syndrome also showing defects in eye and kidney development.
Although there is phenotypic variability in patients identified to
have SALL4 mutations, there is no clear correlation between
specific mutations and phenotypes (Kohlhase et al., 2005).
Unlike SALL1 mutations in TBS, the mutations observed in
these cases do not cluster around a critical region (Kohlhase et
al., 2005) and haploinsuffiency has been shown to be the cause
of these disorders (Borozdin et al., 2004a). The clinical overlap
between these syndromes and TBS reinforces the idea that a
dominant negative effect of a SALL1 truncation on SALL4
function may be involved in TBS.
Spalt proteins in cancer
A possible role for SALL1 in Wilms tumor was reported
when high levels of expression were observed in these cancers
(Ma et al., 2001b). Another spalt gene, SALL2, was shown to be
repressed by the Wilms tumor protein, WT1 (Ma et al., 2001a).
SALL2 is perhaps the most likely candidate for a tumor
suppressor gene as its mouse orthologue binds to the oncogenic
polyoma large T antigen and has been shown to upregulate p21
expression (Li et al., 2001, 2004). SALL1 may also have a role
in tumorigenesis via its ability to enhanceWnt signaling (Sato et
al., 2004). To date, there has been no firm evidence to support
the idea that spalt proteins can act as tumor suppressors.
However, if this were the case, one would predict that
syndromes with either null or dominant negative mutations
would correlate with an increased risk of cancer but this has not
been reported and therefore the case for spalt genes in cancer
aetiology remains speculative.
SALL3 in 18q deletion syndrome
Very little is known about the role of spalt genes in 18q
deletion syndrome which comprises a wide range of develop-
mental defects including mental retardation, hearing loss and
digit abnormalities. Although SALL3 is likely to be lost in these
deletions, it is one of several genes within this region and so
cannot be regarded as the sole cause of this syndrome.
Nevertheless, it remains possible that hemizygosity of SALL3
is responsible for at least some of the features observed in this
syndrome (Kohlhase et al., 1999).
Structure and function of the spalt proteins
Developmental, clinical and biochemical studies have all
contributed to our understanding of how the structure of the
spalt proteins relates to their function. The combination of these
approaches has provided critical insights into how this gene
family operates during development and how mutation can lead
to clinical disorders. In this section, we discuss what is known
about the structure–function relationship of the spalt proteins
and how this knowledge relates to the developmental and
disease aspects of spalt gene activity.
Structure
The spalt proteins range from 105 to 140 kDa and have
several conserved features including an N-terminal zinc finger
domain of the C2HC type (which is not present in Drosophila
spalt proteins), a glutamine-rich region and several double or
triple zinc fingers of the C2H2 type throughout the protein with
the precise number and spacing of these varying across the
family. The predicted structures of the four human spalt proteins
are shown in Fig. 2. In SALL1 group proteins characterized to
date, there are 9 of these C2H2 zinc fingers. However, in the
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other groups, there seems to be variability with respect to zinc
fingers 6 and 7. For example, in the predicted protein structures
of SALL2 and SALL4, zinc fingers 6 and 7 are absent, while
Xsall2, although closest to SALL2 in terms of its protein
sequence, contains additional zinc fingers (Onai et al., 2004). It
is also notable that the C terminal zinc fingers in SALL2 are not
homologous to those seen in other spalt proteins lacking, for
example, the distinctive ‘SAL box’ seen in other zinc fingers in
these proteins. This suggests that these zinc fingers in SALL2
may have a separate origin to those in other spalt proteins. In the
chick, csall3 is missing zinc fingers 6 and 7 compared to SALL3
(Farrell et al., 2001). However, the genomic sequence of csall3
contains a predicted exon containing these missing zinc fingers
and RT-PCR experiments suggest that an alternative splice
variant of csall3, containing these additional zinc fingers, is
expressed during development (DS and AM, unpublished data).
As yet, little is known about the prevalence and extent of
alternative splice forms of the spalt proteins and the possible
functional consequences of this, and this may well prove to be
an important area in the study of these genes.
Transcriptional regulation by spalt genes
Spalt proteins are thought to act as transcription factors
although few target genes have been identified. Support for a
role in transcriptional regulation has come from studies using
fusion proteins of SALL1, Sall1, csall1 and csall3 to the GAL4
DNA binding domain. These fusion proteins are able to repress
transcription from a GAL4 responsive promoter. Furthermore,
in the case of Sall1, this ability was mapped to the N-terminal
zinc finger which has been shown to interact with histone
deactylase to mediate repression (McLeskey Kiefer et al.,
2002; Netzer et al., 2001; Sweetman et al., 2003). To date, the
only demonstration of transcriptional regulation by a vertebrate
spalt on a native promoter has come from studies of SALL2
which has been shown to bind to and regulate the activity of the
CDK inhibitor p21 promoter (Li et al., 2004). Strikingly,
SALL2 binding to the p21 promoter increases transcription and
so provides evidence of positive regulation of transcription by
this family of proteins. SALL1 has also been shown to act as a
positive regulator of β-catenin-dependent Wnt signaling and
this activity correlates with its ability to bind heterochromatin
within the nucleus (Sato et al., 2004). In this study, SALL1 was
shown to interact with β-catenin in coimmunoprecipitation
assays but did not completely colocalize with β-catenin within
the nucleus. The precise role of the spalt proteins in
transcriptional regulation remains to be elucidated although
evidence so far suggests that interactions with other proteins are
likely to be critical in this process (see below). More spalt
responsive promoters will have to be examined in order to
obtain a more complete understanding of the mechanisms by
which spalt proteins affect target gene expression.
Interactions of spalt proteins
The function of the spalt proteins is likely to be modulated
through interactions with other proteins in multi protein
complexes. The spalt proteins themselves can form both
homo- and heteromeric complexes and to date all members of
the family that have been tested show the ability to interact with
each other in coimmunoprecipitation assays (McLeskey Kiefer
et al., 2003; Sweetman et al., 2003). These interactions are
mediated by the N-terminal region of the protein and require the
glutamine-rich region, and proteins lacking this domain do not
coprecipitate. It has been demonstrated that spalt protein
interactions can influence subcellular localization and thereby
potentially modify function. For example, full-length SALL1,
Sall1 and csall1 have all been shown to localize to the nucleus
as expected for a transcriptional regulator (McLeskey Kiefer et
al., 2002; Netzer et al., 2001; Sweetman et al., 2003). However,
csall3 is found in the cytoplasm and, when coexpressed with
csall1, can cause the relocalization of csall1 from the nucleus to
the cytoplasm (Sweetman et al., 2003). The expression pattern
of csall1 and csall3 during limb development is partially
overlapping. This finding, together with the cellular localization
studies, suggests a mechanism whereby the activity of csall1 in
the nucleus can be modulated across the limb bud by
coexpression of csall3, and this may be important for normal
limb development.
Other proteins that have been shown to interact with spalt
proteins include HDAC and β-catenin. In addition, SALL1 has
been shown to interact with TRF1/PIN2 (Netzer et al., 2001),
UBE2I and SUMO-1 (Netzer et al., 2002) and Sall2 with
polyoma virus large T antigen (Li et al., 2001). It will be
important to dissect the implications of these interactions for
spalt protein function in both development and disease.
While it is known that spalt proteins can interact in vitro, it is
not clear if this happens in vivo and, if so, what the
consequences might be. It is possible that target gene expression
may be modified by different combinations of spalt proteins and
this could explain why discrete but overlapping expression
patterns are seen in different regions of the embryo, for example
the developing limb and kidney. There is good evidence for
both repressive and activating functions on target gene
expression, presumably dependent on cellular context. Al-
though GAL4 fusions have uncovered transcriptional repressor
activity and this has been linked to interaction with HDAC, the
only known target gene in vertebrates so far, p21, is upregulated
in the presence of SALL2 (Li et al., 2004). Understanding the
details of these of these processes, including the identification
of further spalt targets, will be critical in our attempts to unravel
the function of this family of proteins in development.
Future directions
One area of interest that requires further elucidation is the
subcellular localization of the spalt proteins. SALL1 and its
orthologues are nuclear, as would be expected of transcription
factors, but at least one family member, csall3 in chick, has been
shown to be cytoplasmic. The ability of csall3 to remove csall1
from the nucleus when both proteins are coexpressed suggests a
role in negative regulation of other spalt proteins. However, this
may not be the whole story. Preliminary data from our lab show
that csall3 undergoes tyrosine phosphorylation while csall1
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does not. Furthermore, upon withdrawal of serum, csall3 can
enter the nucleus (DS and AM, unpublished). This implies a
further level of control of spalt activity where phosphorylation,
induced by growth factors, can alter subcellular localization and
thus potentially transcriptional activity of at least one member
of the spalt family. The possible existence of a splice variant of
Fig. 3. Model of possible spalt protein activities. (A) Combinatorial control of target gene expression within the nucleus by homo- and heteromeric spalt protein
complexes. ‘TBS like’ truncations could interfere with this activity. (B) Cytoplasmic ‘TBS like’ truncations can relocalize full-length protein from the nucleus. (C)
Phosphorylated csal3 protein is cytoplasmic and can relocalize spalt proteins from the nucleus, this may apply to other SALL3 group members.
Table 2
Spalt protein function and regulation
Spalt group Associated disease Interacts with Regulated by Developmental roles Target genes
SALL1 Townes–Brocks
syndrome (Kohlhase
et al., 1998)
sall1, sall3, N terminal
truncations of sall1
(McLeskey Kiefer et al., 2003;
Sweetman et al., 2003)
FGFs/Wnts
(Farrell and
Münsterberg, 2000)
Limb patterning
(McLeskey Kiefer et al., 2003),
kidney development
(Nishinakamura et al., 2001)
HDAC (McLeskey Kiefer
et al., 2002)
BMP
(Capdevila et al., 1999)
UBE21, SUMO-1(Netzer
et al., 2002)
SALL2 N terminal truncations of sall1
(McLeskey Kiefer et al., 2003)
Wilms tumor protein
(Ma et al., 2001a)
None known
(Sato et al., 2003)
p21
(Li et al., 2004)
Polyoma virus large T
(Li et al., 2001)
SALL3 18q23 deletion syndrome (?)
(Kohlhase et al., 1999)
sall1 full-length and
N terminal truncations
(McLeskey Kiefer et al., 2003;
Sweetman et al., 2003)
Palate formation, cranial nerve
development
(Parrish et al., 2004)
SALL4 Okiihiro syndrome
(Kohlhase et al., 2002b)
Holt–Oram and
acro-renal-ocular
syndrome
(Kohlhase et al., 2003a,b)
N terminal truncations of sall1
(McLeskey Kiefer et al., 2003)
Tbx5 (Harvey and
Logan, 2006;
Koshiba-Takeuchi
et al., 2006)
Neural crest development
(Barembaum and
Bronner-Fraser, 2004),
ear development
(M Bronner Fraser, personal
communication),
limb development (Harvey and
Logan, 2006; Koshiba-
Takeuchi et al., 2006)
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csall3 which could alter the localization and therefore function
is also intriguing. Another related question concerns the mode
of action of truncated spalt proteins, such as those potentially
involved in TBS. N terminal truncations of SALL1 group
proteins can remove full-length spalt proteins from the nucleus;
however, a fusion of such an N terminal truncation to the
glucocorticoid receptor shows enhanced repressor activity upon
addition of dexamethasone (Onai et al., 2004). So it appears that
these truncations can act to antagonize full-length protein
function in multiple ways within the cell interfering with protein
function both within and outside the nucleus.
The model shown in Fig. 3 summarizes our current
understanding of spalt protein function. In the nucleus, spalt
proteins may act in combination to activate or repress
expression of target genes while ‘TBS like' truncations can
interfere with this activity (Fig. 3A). ‘TBS like' truncations may
also abrogate the function of full-length spalt proteins by
relocalizing them into the cytoplasm (Fig. 3B). Sall3 proteins
may also act as negative regulators of other spalts by removing
them from the nucleus although this may depend on the
phosphorylation state of the sall3 protein (Fig. 3C).
Conclusions
This review illustrates that the spalt family of proteins are
involved in many fundamental processes during development.
Their roles and mechanisms of action are beginning to be
elucidated by developmental biologists and clinical scientists;
however, many exciting questions remain unanswered. Some of
these aspects of spalt protein biology are summarized in Table 2
and we can look forward to learning more about the diverse
developmental, cellular and molecular roles of this protein
family.
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